- Corporate Officers - S
- Stone Heisz Leslie
Insider Trading History of Stone Heisz Leslie
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stone Heisz Leslie since 2012.
This trader's CIK number is 1235408.
At the time of last reporting, Stone Heisz Leslie was the Director of Edwards Lifesciences Corp. (stock ticker symbol EW).
Also see all insider trading activities at Edwards Lifesciences Corp.
Note that in the past
STONE HEISZ LESLIE also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Public Storage (PSA) by Stone Heisz Leslie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | PSA | 0 | $0 | 13,002 | $4,557,521 | 15,000 | $3,223,550 |
Yearly summary of insider trading at Edwards Lifesciences Corp (EW) by Stone Heisz Leslie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | EW | 0 | $0 | 5,739 | $435,372 | 5,739 | $260,074 |
| 2024 | EW | 0 | $0 | 7,056 | $609,991 | 7,056 | $260,105 |
| 2023 | EW | 0 | $0 | 12,974 | $1,003,452 | 9,671 | $345,032 |
| 2021 | EW | 0 | $0 | 6,707 | $654,066 | 10,000 | $356,770 |
Yearly summary of insider trading at Towers Watson & Co. (TW) by Stone Heisz Leslie
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | TW | 0 | $0 | 0 | $0 | 245 | $0 |
| 2015 | TW | 0 | $0 | 0 | $0 | 61 | $0 |
| 2014 | TW | 0 | $0 | 0 | $0 | 2 | $0 |
| 2013 | TW | 0 | $0 | 0 | $0 | 15 | $0 |
| 2012 | TW | 0 | $0 | 0 | $0 | 1 | $0 |
Insider trading activities at 3 companies by Stone Heisz Leslie:
1. Public Storage (PSA)
2. Edwards Lifesciences Corp (EW)
3. Towers Watson & Co. (TW)
Table 1. Insider trading of Public Storage (PSA) by Stone Heisz Leslie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-15 | PSA | Sale | 9,045 | 362.26 | 3,276,641 |
| 2021-12-15 | PSA | Option Ex | 10,000 | 225.50 | 2,255,000 |
| 2021-08-20 | PSA | Sale | 3,957 | 323.70 | 1,280,880 |
| 2021-08-20 | PSA | Option Ex | 5,000 | 193.71 | 968,550 |
Table 2. Insider trading of Edwards Lifesciences Corp (EW) by Stone Heisz Leslie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-13 | EW | Option Ex | 5,739 | 45.32 | 260,074 |
| 2025-02-13 | EW | Sale | 5,739 | 75.86 | 435,372 |
| 2024-02-08 | EW | Option Ex | 7,056 | 36.86 | 260,105 |
| 2024-02-08 | EW | Sale | 7,056 | 86.45 | 609,991 |
| 2023-08-10 | EW | Sale | 3,303 | 78.87 | 260,507 |
| 2023-02-16 | EW | Option Ex | 9,671 | 35.68 | 345,032 |
| 2023-02-16 | EW | Sale | 9,671 | 76.82 | 742,945 |
| 2021-04-23 | EW | Option Ex | 10,000 | 35.68 | 356,770 |
| 2021-04-23 | EW | Sale | 6,707 | 97.52 | 654,066 |
Table 3. Insider trading of Towers Watson & Co. (TW) by Stone Heisz Leslie
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-04 | TW | Option Ex | 245 | .00 | 0 |
| 2015-12-30 | TW | Option Ex | 59 | .00 | 0 |
| 2015-12-15 | TW | Option Ex | 0 | .00 | 0 |
| 2015-10-15 | TW | Option Ex | 1 | .00 | 0 |
| 2015-07-15 | TW | Option Ex | 0 | .00 | 0 |
| 2015-04-15 | TW | Option Ex | 0 | .00 | 0 |
| 2015-01-15 | TW | Option Ex | 1 | .00 | 0 |
| 2014-10-15 | TW | Option Ex | 1 | .00 | 0 |
| 2014-07-15 | TW | Option Ex | 0 | .00 | 0 |
| 2014-04-15 | TW | Option Ex | 0 | .00 | 0 |
| 2014-01-15 | TW | Option Ex | 1 | .00 | 0 |
| 2013-07-15 | TW | Option Ex | 5 | .00 | 0 |
| 2013-04-15 | TW | Option Ex | 5 | .00 | 0 |
| 2013-01-03 | TW | Option Ex | 5 | .00 | 0 |
| 2012-10-15 | TW | Option Ex | 1 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Stone Heisz Leslie
(Director of Edwards Lifesciences Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.